Cyclophosphamide trials for HIV

All Cyclophosphamide trials · All HIV trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for HIV

• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• CAR-T Cells for HIV Infection
  NCT04648046 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
  NCT05389423 · Phase: Phase 1 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Cyclophosphamide for HIV?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.